Drawing for LIKEMINE

USPTO serial 99524995

LIKEMINE

Reviewed by CopyMark Law Group

Status 688Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
MCCLELLAN, MATTHEW D.
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 688: Status 688 means a Notice of Allowance was issued. For intent-to-use applications, you must file a Statement of Use with specimens or request an extension before the deadline — usually six months from the notice date.

Need help with LIKEMINE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $947*

Plus Government fees of $450

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Laura M. Franco

Laura M. Franco Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.44 Montgomery Street, 36th FloorSan Francisco, CA 94104United States

Goods and services

ClassDescriptionStatusFirst use
009Downloadable mobile applications for planning, tracking and managing pregnancy; downloadable mobile applications for providing personalized reports in self-assessment of pregnancy and the health of the biological parents for the purpose of collecting and analyzing information and preparing reports on the historical rate of certain outcomes in similar pregnancies; downloadable mobile applications for reviewing pregnancy experiences and preparing personalized reports on relevant information regarding pre-pregnancy, pregnancy and post pregnancy; downloadable mobile applications for providing information and reports on different pregnancy experiences and outcomes, questions to ask health care providers regarding pregnancy issues and educational and other information on pregnancy-related topics; downloadable mobile applications for providing links to forums, groups and chats relating to pregnancy; downloadable mobile applications for providing links to referrals to nurses and midwives; Downloadable mobile applications for pregnancy testing, planning, tracking and management, and providing information on pregnancy-related conditions and complications, namely, preterm birth, Cesarean section, gestational diabetes, gestational hypertension, preeclampsia, fetal growth restriction, post-partum depression, placenta previa, ectopic pregnancy, urinary tract infection, multiple births, extrauterine infection, chorioamnionitis, mid/late term bleeding, perinatal sepsis, early bleeding, stillbirth, suspected fetal distress, severe maternal disease; downloadable mobile application for reporting the results of medical testing in the field of pregnancy, and pregnancy-related conditions and complications, namely, preterm birth, Cesarean section, gestational diabetes, gestational hypertension, preeclampsia, fetal growth restriction, post-partum depression, placenta previa, ectopic pregnancy, urinary tract infection, multiple births, extrauterine infection, chorioamnionitis, mid/late term bleeding, perinatal sepsis, early bleeding, stillbirth, suspected fetal distress, severe maternal disease; downloadable mobile applications for laboratory testing services in the fields of pregnancy, pregnancy planning, and pregnancy-related conditions and complications namely, preterm birth, Cesarean section, gestational diabetes, gestational hypertension, preeclampsia, fetal growth restriction, post-partum depression, placenta previa, ectopic pregnancy, urinary tract infection, multiple births, extrauterine infection, chorioamnionitis, mid/late term bleeding, perinatal sepsis, early bleeding, stillbirth, suspected fetal distress, severe maternal disease; downloadable mobile applications for medical laboratory analysis services in the fields of pregnancy, pregnancy planning and pregnancy-related conditions and complications namely, preterm birth, Cesarean section, gestational diabetes, gestational hypertension, preeclampsia, fetal growth restriction, post-partum depression, placenta previa, ectopic pregnancy, urinary tract infection, multiple births, extrauterine infection, chorioamnionitis, mid/late term bleeding, perinatal sepsis, early bleeding, stillbirth, suspected fetal distress, severe maternal disease; downloadable computer software in the nature of downloadable mobile applications for providing virtual appointments to discuss personalized reports in self-assessment of pregnancy and the health of the biological parents for the purpose of collecting and analyzing information and preparing reports on the historical rate of certain outcomes in similar pregnancies; downloadable computer software in the nature of downloadable mobile applications for providing virtual appointments to discuss pregnancy experiences and preparing personalized reports on relevant information regarding pre-pregnancy, pregnancy and post pregnancy; downloadable computer software in the nature of downloadable mobile applications for providing virtual appointments to discuss relevant information about the different pregnancy experiences and outcomes, questions to ask their health care providers regarding pregnancy, pregnancy topics and pregnancy issues; downloadable computer software in the nature of downloadable mobile applications for providing virtual appointments to discuss on a periodic basis relevant information on pregnancy, pregnancy topics and pregnancy issues; downloadable computer software in the nature of downloadable mobile applications for providing pregnancy tracking tools, checklists, and calendars for tracking pregnancy, blood pressure, fetus development, weight and preparing for childbirth; downloadable computer software in the nature of downloadable mobile applications for symptoms monitoring for pregnancy complications; downloadable computer software in the nature of downloadable mobile applications for connecting women to provide communities of support, friendship and advice; downloadable computer software in the nature of downloadable mobile applications for creating personalized reports regarding pregnancy experiences and outcomes; downloadable computer software in the nature of downloadable mobile applications offering retail store services featuring blood testsACTIVE—
042Medical research services; medical research laboratory services relating to medical research in the field of pregnancy, pregnancy-related features, issues, conditions and complications, pregnancy planning, pregnancy tracking and management; Software as a service (SAAS) services featuring software for providing virtual appointments to discuss personalized reports in self-assessment of pregnancy and the health of the biological parents for the purpose of collecting and analyzing information and preparing reports on the historical rate of certain outcomes in similar pregnancies; Software as a service (SAAS) services featuring software for providing virtual appointments to discuss pregnancy experiences and preparing personalized reports on relevant information regarding pre-pregnancy, pregnancy and post pregnancy; Software as a service (SAAS) services featuring software for providing virtual appointments to discuss pregnancy experiences and outcomes, questions to ask their health care providers regarding pregnancy, pregnancy topics and pregnancy issues; Software as a service (SAAS) services featuring software for providing virtual appointments to discuss on a periodic basis relevant information on pregnancy, pregnancy topics and pregnancy issues; Software as a service (SAAS) services featuring software for providing virtual appointments for symptoms monitoring for pregnancy complications; Software as a service (SAAS) services featuring software for connecting women to provide communities of support, friendship and advice; Software as a service (SAAS) services featuring software for creating personalized reports regarding pregnancy experiences and outcomes; Software as a service (SAAS) services featuring software for purchasing goods in the field of blood tests; Software as a service (SAAS) services featuring software for providing pregnancy tracking tools, checklists, and calendars for tracking pregnancy, blood pressure, fetus development, weight and preparing for childbirth; Blood testing for scientific research purposesACTIVE—
044Medical testing services for pregnancy, pregnancy planning, tracking and management, and pregnancy-related conditions; medical diagnostic testing services to detect pregnancy and for pregnancy planning, tracking and management, and for pregnancy-related health issues and complications, namely preterm birth, Cesarean section, gestational diabetes, gestational hypertension, preeclampsia, fetal growth restriction, post-partum depression, placenta previa, ectopic pregnancy, urinary tract infection, multiple births, extrauterine infection, chorioamnionitis, mid/late term bleeding, perinatal sepsis, early bleeding, stillbirth, suspected fetal distress, severe maternal disease; Medical laboratory analysis services in the fields of pregnancy testing, pregnancy planning, tracking and management, and pregnancy-related conditions and complications namely, preterm birth, Cesarean section, gestational diabetes, gestational hypertension, preeclampsia, fetal growth restriction, post-partum depression, placenta previa, ectopic pregnancy, urinary tract infection, multiple births, extrauterine infection, chorioamnionitis, mid/late term bleeding, perinatal sepsis, early bleeding, stillbirth, suspected fetal distress, severe maternal disease; Medical testing services; Medical testing of blood; Medical testing services to predict risk of pre-term birth, pre-term labor, preeclampsia, gestational diabetes, gestation hypertension, fetal growth restriction, and post-partum depression, Cesarean section, gestational diabetes, gestational hypertension, preeclampsia, fetal growth restriction, post-partum depression, placenta previa, ectopic pregnancy, urinary tract infection, multiple births, extrauterine infection, chorioamnionitis, mid/late term bleeding, perinatal sepsis, early bleeding, stillbirth, suspected fetal distress, severe maternal disease; Providing information on pregnancy and pregnancy related health topics, namely, preterm birth, Cesarean section, gestational diabetes, gestational hypertension, preeclampsia, fetal growth restriction, post-partum depression, placenta previa, ectopic pregnancy, urinary tract infection, multiple births, extrauterine infection, chorioamnionitis, mid/late term bleeding, perinatal sepsis, early bleeding, stillbirth, suspected fetal distress, severe maternal disease, menstrual disorders, infertility, endometriosis, uterine fibroids, polycystic ovary syndrome, sexually transmitted infections, and menopause; Providing medical diagnostic testing services to predict risk of and to detect pregnancy related conditions and complications, including preterm birth, pre-term labor, preeclampsia, gestational diabetes, gestation hypertension, fetal growth restriction, post-partum depression, Cesarean section, placenta previa, ectopic pregnancy, urinary tract infection, multiple births, extrauterine infection, chorioamnionitis, mid/late term bleeding, perinatal sepsis, early bleeding, stillbirth, fetal distress, severe maternal disease; medical testing for pregnancy, pregnancy-related features, issues, conditions and complications, pregnancy planning, pregnancy tracking and managementACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (NOAM): A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.

DateCodeEventWhat it means
Jul 14, 2026NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
May 19, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 19, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 13, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 20, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 17, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 17, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 17, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 14, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 14, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 14, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 6, 2026DOCKASSIGNED TO EXAMINER—
Mar 20, 2026EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Mar 20, 2026TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 20, 2026ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 20, 2026REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Feb 12, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 2, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Dec 2, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance